Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | SAVA |
---|---|---|
09:32 ET | 13024 | 28.825 |
09:34 ET | 22701 | 29.3 |
09:36 ET | 24957 | 29.7084 |
09:38 ET | 26534 | 29.575 |
09:39 ET | 22815 | 29.4 |
09:41 ET | 39491 | 28.56 |
09:43 ET | 10948 | 28.716 |
09:45 ET | 4782 | 28.66 |
09:48 ET | 5982 | 28.77 |
09:50 ET | 4700 | 28.9 |
09:52 ET | 15555 | 29.175 |
09:54 ET | 10179 | 29.4 |
09:56 ET | 19457 | 29.0713 |
09:57 ET | 625 | 29.3137 |
09:59 ET | 7679 | 28.9311 |
10:01 ET | 11347 | 28.93 |
10:03 ET | 32901 | 28.22 |
10:06 ET | 5538 | 28.3252 |
10:08 ET | 4143 | 28.4303 |
10:10 ET | 2571 | 28.61 |
10:12 ET | 9420 | 28.5404 |
10:14 ET | 16791 | 28.875 |
10:15 ET | 5227 | 28.68 |
10:17 ET | 3154 | 28.765 |
10:19 ET | 3400 | 28.69 |
10:21 ET | 2814 | 28.46 |
10:24 ET | 32802 | 28.2226 |
10:26 ET | 1601 | 28.24 |
10:28 ET | 1927 | 28.395 |
10:30 ET | 13104 | 28.45 |
10:32 ET | 8935 | 28.47 |
10:33 ET | 16756 | 28.11 |
10:35 ET | 12502 | 28 |
10:37 ET | 5594 | 28.11 |
10:39 ET | 1735 | 28.03 |
10:42 ET | 2246 | 28.1195 |
10:44 ET | 1581 | 28.1632 |
10:46 ET | 12681 | 28.24 |
10:48 ET | 5672 | 28.2705 |
10:50 ET | 18540 | 28.3902 |
10:51 ET | 3230 | 28.435 |
10:53 ET | 4731 | 28.48 |
10:55 ET | 3924 | 28.32 |
10:57 ET | 1829 | 28.2402 |
11:02 ET | 4013 | 28.5383 |
11:04 ET | 4386 | 28.27 |
11:06 ET | 900 | 28.35 |
11:08 ET | 4055 | 28.415 |
11:09 ET | 3515 | 28.37 |
11:11 ET | 200 | 28.4 |
11:13 ET | 7930 | 28.4925 |
11:15 ET | 27214 | 28.77 |
11:18 ET | 6854 | 28.67 |
11:20 ET | 3317 | 28.6004 |
11:22 ET | 1250 | 28.7 |
11:24 ET | 2044 | 28.84 |
11:26 ET | 8084 | 28.835 |
11:27 ET | 3282 | 28.92 |
11:29 ET | 10451 | 29.0397 |
11:31 ET | 7752 | 29.1201 |
11:33 ET | 45294 | 29.629 |
11:36 ET | 91144 | 30.31 |
11:38 ET | 38997 | 30.325 |
11:40 ET | 21717 | 29.705 |
11:42 ET | 5886 | 29.84 |
11:44 ET | 4686 | 29.7758 |
11:45 ET | 9303 | 30 |
11:47 ET | 10609 | 29.9192 |
11:49 ET | 16955 | 29.81 |
11:51 ET | 11846 | 30 |
11:54 ET | 2976 | 30.02 |
11:56 ET | 3877 | 30.055 |
11:58 ET | 9208 | 29.9155 |
12:00 ET | 7537 | 29.691 |
12:02 ET | 6646 | 29.7716 |
12:03 ET | 3614 | 29.6595 |
12:05 ET | 2632 | 29.7401 |
12:07 ET | 2850 | 29.735 |
12:09 ET | 10906 | 29.9201 |
12:12 ET | 3395 | 30.0975 |
12:14 ET | 50204 | 30.5687 |
12:16 ET | 22184 | 30.59 |
12:18 ET | 8771 | 30.66 |
12:20 ET | 17045 | 30.54 |
12:21 ET | 14411 | 30.44 |
12:23 ET | 5399 | 30.4 |
12:25 ET | 8057 | 30.3 |
12:27 ET | 5384 | 30.5099 |
12:30 ET | 2689 | 30.51 |
12:32 ET | 14531 | 30.55 |
12:34 ET | 9351 | 30.42 |
12:36 ET | 3277 | 30.5144 |
12:38 ET | 11755 | 30.643 |
12:39 ET | 6058 | 30.665 |
12:41 ET | 1155 | 30.6 |
12:43 ET | 1808 | 30.5862 |
12:45 ET | 8651 | 30.6 |
12:48 ET | 1394 | 30.68 |
12:50 ET | 45525 | 30.985 |
12:52 ET | 13498 | 30.96 |
12:54 ET | 38862 | 31.515 |
12:56 ET | 17902 | 31.31 |
12:57 ET | 9168 | 31.325 |
12:59 ET | 9110 | 31.2755 |
01:01 ET | 20172 | 30.8821 |
01:03 ET | 22719 | 30.685 |
01:06 ET | 20795 | 30.425 |
01:08 ET | 8041 | 30.33 |
01:10 ET | 13230 | 30.42 |
01:12 ET | 2692 | 30.365 |
01:14 ET | 9054 | 30.6548 |
01:15 ET | 9564 | 30.3093 |
01:17 ET | 10817 | 30.54 |
01:19 ET | 6280 | 30.5203 |
01:21 ET | 4503 | 30.528 |
01:24 ET | 1905 | 30.45 |
01:26 ET | 6155 | 30.85 |
01:28 ET | 9536 | 30.79 |
01:30 ET | 4011 | 30.7889 |
01:32 ET | 4107 | 30.525 |
01:33 ET | 7990 | 30.59 |
01:35 ET | 2709 | 30.595 |
01:37 ET | 7582 | 30.6816 |
01:39 ET | 9036 | 30.465 |
01:42 ET | 8462 | 30.44 |
01:44 ET | 9826 | 30.4419 |
01:46 ET | 11400 | 30.2501 |
01:48 ET | 39612 | 29.73 |
01:50 ET | 50615 | 29.385 |
01:51 ET | 30275 | 29.2273 |
01:53 ET | 10659 | 29.39 |
01:55 ET | 5890 | 29.39 |
01:57 ET | 22002 | 29.13 |
02:00 ET | 8508 | 29.35 |
02:02 ET | 8651 | 29.5 |
02:04 ET | 4641 | 29.7 |
02:06 ET | 4458 | 29.92 |
02:08 ET | 7793 | 30.01 |
02:09 ET | 21492 | 29.96 |
02:11 ET | 6934 | 30.1 |
02:13 ET | 7812 | 30.11 |
02:15 ET | 5416 | 30.026 |
02:18 ET | 26566 | 30.23 |
02:20 ET | 5216 | 30.2164 |
02:22 ET | 11903 | 30.2 |
02:24 ET | 3648 | 30.295 |
02:26 ET | 15803 | 30.51 |
02:27 ET | 14615 | 30.649 |
02:29 ET | 27882 | 30.8309 |
02:31 ET | 8203 | 30.66 |
02:33 ET | 9385 | 30.57 |
02:36 ET | 1903 | 30.5149 |
02:38 ET | 3364 | 30.5881 |
02:40 ET | 16296 | 30.4215 |
02:42 ET | 8581 | 30.61 |
02:44 ET | 8540 | 30.5631 |
02:45 ET | 2074 | 30.53 |
02:47 ET | 5728 | 30.3658 |
02:49 ET | 6886 | 30.5 |
02:51 ET | 19158 | 30.51 |
02:54 ET | 1600 | 30.4 |
02:56 ET | 1274 | 30.38 |
02:58 ET | 5998 | 30.43 |
03:00 ET | 3953 | 30.4204 |
03:02 ET | 100 | 30.42 |
03:03 ET | 9179 | 30.5 |
03:05 ET | 3182 | 30.35 |
03:07 ET | 6317 | 30.42 |
03:09 ET | 5725 | 30.4 |
03:12 ET | 2006 | 30.405 |
03:14 ET | 700 | 30.3501 |
03:16 ET | 2900 | 30.4 |
03:18 ET | 1400 | 30.5 |
03:20 ET | 1000 | 30.4 |
03:21 ET | 250 | 30.435 |
03:23 ET | 6715 | 30.46 |
03:25 ET | 11682 | 30.535 |
03:27 ET | 3825 | 30.4 |
03:30 ET | 7000 | 30.37 |
03:32 ET | 3703 | 30.38 |
03:34 ET | 8385 | 30.5 |
03:36 ET | 3908 | 30.4 |
03:38 ET | 11780 | 30.46 |
03:39 ET | 4696 | 30.4 |
03:41 ET | 14741 | 30.7914 |
03:43 ET | 13351 | 30.79 |
03:45 ET | 7031 | 30.56 |
03:48 ET | 19175 | 30.62 |
03:50 ET | 7077 | 30.5786 |
03:52 ET | 6867 | 30.44 |
03:54 ET | 9338 | 30.4 |
03:56 ET | 10513 | 30.45 |
03:57 ET | 13135 | 30.42 |
03:59 ET | 99229 | 30.46 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Cassava Sciences Inc | 1.4B | -75.1x | --- |
Longboard Pharmaceuticals Inc | 1.3B | -16.9x | --- |
Spyre Therapeutics Inc | 1.3B | -1.8x | --- |
Disc Medicine Inc | 1.4B | -13.5x | --- |
ARS Pharmaceuticals Inc | 1.3B | -30.6x | --- |
Centessa Pharmaceuticals PLC | 1.4B | -7.9x | --- |
Cassava Sciences, Inc. is a clinical-stage biopharmaceutical company focused on neuroscience. The Company's science is based on stabilizing, but not removing, a critical protein in the Alzheimer’s brain. Its scientific approach for the treatment of Alzheimer's disease seeks to simultaneously suppress both neurodegeneration and neuroinflammation. It has two biopharmaceutical assets under development: Simufilam and SavaDx. Simufilam, its lead therapeutic product candidate, is an oral treatment for Alzheimer’s disease dementia. Simufilam targets an altered form of a protein called filamin A (FLNA) in the Alzheimer’s brain. It is conducting two randomized placebo-controlled Phase III clinical trials of oral simufilam in patients with Alzheimer’s disease dementia. SavaDx, its lead investigational diagnostic product candidate, is a way to detect the presence of Alzheimer’s disease from a small sample of blood. SavaDx is a research-use only, non-safety related exploratory biomarker.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.4B |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 48.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.64 |
EPS | $-0.41 |
Book Value | $3.25 |
P/E Ratio | -75.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.